圣达生物(603079.SH)：预计2025年净利润同比增长69.93%至120.90%

Core Viewpoint - The company, 圣达生物, expects significant growth in net profit for the year 2025, with projections indicating an increase of 69.93% to 120.90% compared to the previous year [1] Financial Projections - The company anticipates a net profit attributable to shareholders of the parent company to be between 50 million and 65 million yuan for 2025 [1] - The projected net profit, excluding non-recurring gains and losses, is expected to be between 43 million and 58 million yuan, reflecting a year-on-year growth of 91.42% to 158.19% [1] Operational Improvements - The company has enhanced operational efficiency and cost structure through continuous fine management and technological upgrades [1] - A differentiated competitive strategy has been deepened, with increased market expansion efforts to seize market opportunities, contributing to overall profitability improvement [1]